Organigram (TSE:OGI) Stock Falls 3.6% – Time to Sell?

Organigram Holdings Inc. (TSE:OGI)’s stock price was down 3.6% during mid-day trading on Tuesday. The stock traded as low as C$1.28 and last traded at C$1.32. 122,204 shares changed hands during mid-day trading, a decline of 38% from the average session volume of 197,245 shares. The stock had previously closed at C$1.37.

Organigram Stock Performance

The stock has a market capitalization of C$190.28 million, a P/E ratio of 2.20, a PEG ratio of 0.42 and a beta of 1.64. The stock’s 50-day simple moving average is C$1.54 and its 200 day simple moving average is C$1.58. The company has a debt-to-equity ratio of 6.48, a current ratio of 2.61 and a quick ratio of 2.62.

Organigram (TSE:OGI) last announced its earnings results on Tuesday, August 11th. The company reported C$0.77 EPS for the quarter. The business had revenue of C$105.78 million during the quarter. Organigram had a net margin of 28.02% and a return on equity of 21.99%. Research analysts expect that Organigram Holdings Inc. will post 0.16 EPS for the current fiscal year.

About Organigram

Organigram Global Inc is listed on the NASDAQ Global Select Market and TSX. The Company’s wholly owned subsidiary, Organigram Inc, is a licensed cultivator and processor. Through its acquisition of Sanity Group GmbH (‘Sanity Group’), Organigram participates in the German medical cannabis market and other emerging markets within Europe. Organigram is focused on producing high-quality cannabis for adult consumers, as well as extending the Company’s global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O’ Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK.